Galenical formulation comprising aliskiren and process for its preparation by melt extrusion granulation

Details for Australian Patent Application No. 2009296718 (hide)

Owner Novartis AG

Inventors Ghosh, Indrajit; Kowalski, James; Snyder, Jennifer; Tong, Wei-Qin; Vippagunta, Sudha

Agent Davies Collison Cave

Pub. Number AU-A-2009296718

PCT Pub. Number WO2010/036686

Priority 61/161,799 20.03.09 US; 61/099,595 24.09.08 US

Filing date 23 September 2009

Wipo publication date 1 April 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

24 March 2011 PCT application entered the National Phase

  PCT publication WO2010/036686 Priority application(s): WO2010/036686

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296719-Grease collecting filter assembly and method of fabrication thereof

2009296717-Carton with locking sections